Disc Medicine (IRON) Interest & Investment Income (2020 - 2026)
Disc Medicine (IRON) reported Interest & Investment Income of $6.9 million for Q1 2026, little changed year-over-year from $6.9 million in Q1 2025, and down 7.0% on a QoQ basis from $7.4 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Interest & Investment Income data on file, last reported at $6.9 million in Q1 2026.
- Quarterly Interest & Investment Income changed 0.19% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.8 million (up 17.42% YoY) and the FY2025 annual result came in at $27.8 million, up 30.38% from the prior year.
- Interest & Investment Income fell to $6.9 million in Q1 2026 per IRON's latest filing, from $7.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.4 million in Q4 2025 and bottomed at $7000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $4.7 million (2023), against an average of $4.2 million.
- The widest annual swing landed in 2023, when Interest & Investment Income surged 33714.29%; it then gained 0.19% in 2026.
- Tracing IRON's Interest & Investment Income over 5 years: stood at $388000.0 in 2022, then jumped by 1105.41% to $4.7 million in 2023, then increased by 24.82% to $5.8 million in 2024, then advanced by 26.96% to $7.4 million in 2025, then declined by 7.0% to $6.9 million in 2026.
- Per Business Quant, the three latest IRON Interest & Investment Income figures stand at $6.9 million (Q1 2026), $7.4 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 6.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 7.41 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 4.68 Mn |
| Sep 30, 2023 | 4.84 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.37 Mn |
| Dec 31, 2022 | 388,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 4,533.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 36,000.00 |